ISSN:

Journal Home

Journal for ImmunoTherapy of Cancer Q1 Unclaimed

BMJ Publishing Group United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal for ImmunoTherapy of Cancer is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 117. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1694 €. The scope of the journal is focused on tumour immunology, cancer immunotherapy, immunotherapy biomarkers. It has an SJR impact factor of 3,728 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,728.

Journal for ImmunoTherapy of Cancer focuses its scope in these topics and keywords: cancer, immunotherapy, response, annual, tumor, patient, society, carcinoma, cell, therapy, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1) Immunology (Q1) Immunology and Allergy (Q1) Immunology and Allergy (Q1) Molecular Medicine (Q1) Oncology (Q1) Pharmacology (Q1)

Price

1694 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

3,728

SJR Impact factor

117

H Index

445

Total Docs (Last Year)

1590

Total Docs (3 years)

19408

Total Refs

14743

Total Cites (3 years)

1571

Citable Docs (3 years)

8.71

Cites/Doc (2 years)

43.61

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Pharmacological Reviews Q1
Drug Resistance Updates Q1
Annual Review of Pharmacology and Toxicology Q1
Molecular Therapy Q1
Trends in Pharmacological Sciences Q1

Compare this journals